Statistics for Tyra Biosciences, (id:7937 TYRA)
Valuation metrics
Market cap
801.05M
Enterprise value
458.30M
Trailing P/E (ttm)
-9.77
Forward P/E
-7.84
PEG ratio
-7.84
Price/Sales (ttm)
Price/Book (mrq)
2.31
Enterprise Value/Revenue
Enterprise Value/EBITDA
-4.60
Overview
Shares outstanding
50.60M
Float
10.42M
Shares short
1.76M
% Held by insiders
0.05%
% Held by institutions
0.99%
Average volume (10 days)
278.97K
Average volume (90 days)
Price summary
52-Week low
10.60
52-Week high
29.60
52-Week change
29.18%
Beta
1.08
50-Day moving average
20.89
200-Day moving average
19.22
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-20.21%
Return on equity
-28.66%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-99,594,000.00
Net income to common (ttm)
-83,740,000.00
Diluted EPS (ttm)
-1.61
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
360.13M
Total cash per share (mrq)
6.81
Total debt (mrq)
6.32M
Total Debt/Equity (mrq)
1.74
Current ratio (mrq)
2.95K%
Book value per share (mrq)
6.85
Cash flow
Cash flow statement
-63,716,000.00
Levered free cash flow (LFCF)
-37,571,876.00